Facile preparation of salivary extracellular vesicles for cancer proteomics

Extracellular vesicles (EVs) are membrane surrounded structures released by cells, which have been increasingly recognized as mediators of intercellular communication. Recent reports indicate that EVs participate in important biological processes and could serve as potential source for cancer biomarkers. As an attractive EVs source with merit of non-invasiveness, human saliva is a unique medium for clinical diagnostics. Thus, we proposed a facile approach to prepare salivary extracellular vesicles (SEVs). Affinity chromatography column combined with filter system (ACCF) was developed to efficiently remove the high abundant proteins and viscous interferences of saliva. Protein profiling in the SEVs obtained by this strategy was compared with conventional centrifugation method, which demonstrated that about 70% more SEVs proteins could be revealed. To explore its utility for cancer proteomics, we analyzed the proteome of SEVs in lung cancer patients and normal controls. Shotgun proteomic analysis illustrated that 113 and 95 proteins have been identified in cancer group and control group, respectively. Among those 63 proteins that have been consistently discovered only in cancer group, 12 proteins are lung cancer related. Our results demonstrated that SEVs prepared through the developed strategy are valuable samples for proteomics and could serve as a promising liquid biopsy for cancer.

[1]  M. Baj-Krzyworzeka,et al.  [Characterization and biological role of extracellular vesicles]. , 2014, Postepy higieny i medycyny doswiadczalnej.

[2]  J J Sixma,et al.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. , 1999, Blood.

[3]  J. Sixma,et al.  Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules , 1999 .

[4]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[5]  R. Richardson,et al.  Prominin1 marks intestinal stem cells that are susceptible to neoplastic transformation , 2008, Nature.

[6]  Hua Xiao,et al.  Proteomic analysis of microvesicles in human saliva by gel electrophoresis with liquid chromatography-mass spectrometry. , 2012, Analytica chimica acta.

[7]  J. Inal,et al.  Blood/plasma secretome and microvesicles. , 2013, Biochimica et biophysica acta.

[8]  Aled Clayton,et al.  Adhesion and signaling by B cell‐derived exosomes: the role of integrins , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  L. Tanoue,et al.  Molecular Origins of Cancer. Lung Cancer , 2010 .

[10]  David Elashoff,et al.  Salivary Proteomics for Oral Cancer Biomarker Discovery , 2008, Clinical Cancer Research.

[11]  R. Rosell,et al.  Lung cancer in 2014: Optimizing lung cancer treatment approaches , 2015, Nature Reviews Clinical Oncology.

[12]  Y. Gho,et al.  Proteomics in gram-negative bacterial outer membrane vesicles. , 2008, Mass spectrometry reviews.

[13]  Gerald A. Hudgens,et al.  Salivary α‐amylase as a measure of endogenous adrenergic activity , 1996 .

[14]  Hua Xiao,et al.  Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection , 2016, Scientific Reports.

[15]  D. Chia,et al.  Role of Pancreatic Cancer-derived Exosomes in Salivary Biomarker Development* , 2013, The Journal of Biological Chemistry.

[16]  D. Wong,et al.  Breast Cancer Exosome-like Microvesicles and Salivary Gland Cells Interplay Alters Salivary Gland Cell-Derived Exosome-like Microvesicles In Vitro , 2012, PloS one.

[17]  F. V. Winck,et al.  Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles , 2015, Scientific Reports.

[18]  M. Ratajczak,et al.  Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes , 2006, Cancer Immunology, Immunotherapy.

[19]  S. Oh,et al.  Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway , 2012, Oncogene.

[20]  David Elashoff,et al.  Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer , 2010, PloS one.

[21]  David Elashoff,et al.  Development of transcriptomic biomarker signature in human saliva to detect lung cancer , 2012, Cellular and Molecular Life Sciences.

[22]  G A Hudgens,et al.  Salivary alpha-amylase as a measure of endogenous adrenergic activity. , 1996, Clinical physiology.

[23]  David Elashoff,et al.  Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. , 2010, Gastroenterology.

[24]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[25]  Lei Zhang,et al.  Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.

[26]  Hong-Jian Zhu,et al.  Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components , 2013, Proteomics.

[27]  O. Farokhzad,et al.  Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. , 2015, The Journal of clinical investigation.

[28]  M. Lerman,et al.  Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer , 2010, BMC Cancer.

[29]  K. Pantel,et al.  Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. , 2008, Lung cancer.

[30]  J. Inal,et al.  Microvesiculation and disease. , 2013, Biochemical Society transactions.

[31]  Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium , 2015, Clinical Proteomics.

[32]  Y. Fleissig,et al.  An approach to remove alpha amylase for proteomic analysis of low abundance biomarkers in human saliva , 2008, Electrophoresis.

[33]  A. Vissink,et al.  Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. , 2007, Arthritis and rheumatism.

[34]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[35]  N. Maltsev,et al.  Microvesicles and intercellular communication in the context of parasitism , 2013, Front. Cell. Infect. Microbiol..

[36]  L. Journet,et al.  Improved methods for producing outer membrane vesicles in Gram-negative bacteria. , 2004, Research in microbiology.

[37]  R. Sathawane,et al.  Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma , 2012, Clinical Oral Investigations.

[38]  Li Gang,et al.  Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells , 2015, PloS one.

[39]  C. Giacomantonio,et al.  Annexin A2 is a novel Cellular Redox Regulatory Protein involved in Tumorigenesis , 2011, Oncotarget.

[40]  Fang Wei,et al.  Detection of Tumor Cell-Specific mRNA and Protein in Exosome-Like Microvesicles from Blood and Saliva , 2014, PloS one.

[41]  P. Massion,et al.  The State of Molecular Biomarkers for the Early Detection of Lung Cancer , 2012, Cancer Prevention Research.

[42]  I. Matsumoto,et al.  Regulatory roles of tumor necrosis factor alpha-induced proteins (TNFAIPs) 3 and 9 in arthritis. , 2014, Clinical immunology.

[43]  J. Duarte,et al.  Analysis of the human saliva proteome , 2005, Expert review of proteomics.

[44]  Yan Du,et al.  Clinical and experimental studies regarding the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer , 2013, BMC Cancer.

[45]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.